CARE project resources

where public deliverables and Annual summary reports will be available

About IMI

IMI is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. IMI is a joint undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

For further details please visit:

IMI has funded seven other projects fighting COVID-19 in Spring 2020:

  • COVID-RED: COVID-19 infections – Remote Early Detection
  • DECISION: A miniaturized disposable molecular diagnostics platform for combatting coronavirus infections
  • DRAGON: Rapid and secure AI imaging based diagnosis, stratification, follow-up, and preparedness for coronavirus pandemics
  • Impentri: Development of an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)
  • KRONO: Evaluation of a production ready portable, point-of-need platform (instrument and reagents), direct from nasal swab test for the molecular diagnostic detection of COVID-19 infection
  • MAD-CoV 2: Modern approaches for developing antivirals against SARS-CoV-2
  • RAPID-COVID: Robust automation and point of care identification of COVID